Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants (NCT00992303)
Tissue Procurement and Outcome Collection for Radiotherapy Treated Patients and Healthy Participants
🩺 Plain-English Summary (8th-Grade Level)
RATIONALE: Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting tissue samples from patients with cancer undergoing radiation therapy. Healthy participants will also be allowed on the trial so their samples can be used in comparison to patients with malignancy
Who can join: Review the eligibility criteria below.
Location: UT Southwestern Medical Center — Dallas, Texas
Age range: 18 Years
🧪 Interventions in This Study
- biologic sample preservation procedure (OTHER)
- medical chart review (OTHER)
- questionnaire administration (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- UT Southwestern Medical Center — Dallas, Texas
📞 Contact the Study Coordinator
Phone: (214) 645-8525
Email: suprabha.pulipparacharuvil@utsouthwestern.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Unspecified Adult Solid Tumor, Protocol Specific
- Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors — Winston-Salem, North Carolina
- Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors — Palo Alto, California
- RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists — Duarte, California
Explore by condition: All Unspecified Adult Solid Tumor, Protocol Specific clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.